Development of an analytical method using reversed-phase HPLC-PDA for a semipurified extract of Paullinia cupana var. sorbilis (guaraná)  by Klein, Traudi et al.
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a  b  s  t  r  a  c  t
The  Neotropical  plant  ‘guaraná’  has  been  widely  used  in  medicine,  cosmetics,  and  industry  because  of
its versatile  biological  activities.  These  effects  are  mainly  attributed  to  the  presence  of  polyphenols.  An
efﬁcient,  precise,  and  reliable  method  was  developed  for quantiﬁcation  of the  polyphenols  catechin  and
epicatechin  in guaraná  extract  solution,  using  HPLC-PDA  detection.  The  ideal  conditions  for  the  analysis
of a  semipuriﬁed  extract  of  guaraná  (EPA),  using  solutions  of  0.05%  TFA–water  (phase  A) and  0.05%  TFA
in  acetonitrile:methanol  (75:25,  v  v−1)  (phase  B)  as  mobile  phases  were  established.  Gradient  reversed-
phase  chromatography  was  performed  using  a  guard  cartridge  (C18,  4.6  mm  × 20  mm,  4  m)  and  column
(C18,  250  mm  ×  4.6 mm,  4 m), ﬂow  of  0.5  mL  min−1 and  detection  at 280  nm.  The  main  validation  param-
eters  of the  method  were  also  determined.  The  method  was  linear  over  a range  of  18.75–300  g mL−1
for  catechin  and  epicatechin,  with  detection  limits  of 0.70  and  0.88  g mL−1 and  quantiﬁcation  limits  of
2.13  and  2.67  g  mL−1, respectively.  The  method  also  showed  consistent  mean  recoveries  of  91.3  ±  3.8%,
2.14  RSD  and  93.4  ±  3.1,  2.74  RSD  of  catechin  and  epicatechin  respectively.  The  relative  standard  devi-
ations  were  relatively  low:  intra-day  (0.72%  and  0.66%  for  catechin  and  epicatechin,  respectively)  and
inter-day  (0.93%  and  0.75%  for catechin  and  epicatechin,  respectively).  The  semipuriﬁed  extract  showed
catechin,  epicatechin,  and  caffeine  contents  of  180.75,  278.87,  and  300.87  g  mg−1, respectively.  The
results  demonstrated  the  efﬁciency,  precision,  accuracy,  and  robustness  of  the  proposed  method.  The
solutions  remained  stable  for a sufﬁcient  time  (one  week)  to  complete  the  analytical  process.. Introduction
The guaraná plant (Paullinia cupana var. sorbilis (Mart.) Ducke,
apindaceae) is widely distributed in the Amazon region and also
rows in northeastern Brazil, including the state of Bahia. Its seeds,
sed in popular medicine, contain large amounts of methylxan-
hines including caffeine, theophylin and theobromin, saponins,
nd polyphenols, especially tannins [1,2]. Guaraná extract is used
s a stimulant of the central nervous system, in cases of physical and
ental stress, and as an antidiarrheal, diuretic, and antineuralgic
1,3]. The antidepressive effect has been reported to be comparable
o that of the tricyclic antidepressant imipramine, and with a bene-
cial effect on cognition, without altering locomotor activity [4–8].
uaraná extract also shows low toxicity, with antioxidant and anti-
mnesiac effects [5,6,9–11], potential effect as a chemoprophylactic
n carcinogenesis [9],  and potential antibactericidal activity against
treptococcus mutans,  a cause of bacterial dental plaque [3].
Chemical assay of a semipuriﬁed fraction of guaraná (EPA)
howed the presence of caffeine, epicatechin, catechin, ent-
∗ Corresponding author. Tel.: +55 44 3011 4816; fax: +55 44 3011 5050.
E-mail address: mello@uem.br (J.C.P. de Mello).
039-9140 © 2011 Elsevier B.V.  
oi:10.1016/j.talanta.2011.11.023
Open access under the Elsevier OA license.© 2011 Elsevier B.V. 
epicatechin and procyanidins B1–B4, A2 and C1 [2,3]. This fraction
showed an antidepressant effect on animals that received chronic
treatment. This activity could not be related to the methylxan-
thins present, because when caffeine is tested in isolation, the
effects differ from those of the EPA fraction. This suggests that
the activity results from the presence of other constituents, and
the condensed tannins may  be the responsible agents; condensed
tannins can cross the blood–brain barrier and act on the central ner-
vous system [2,5,6,12]. Previous studies found that the EPA fraction
of guaraná caused no toxicity in rats at the smallest dose evaluated
(30 mg  kg−1) [13].
The potential for using guaraná in a wide range of medicinal
applications justiﬁes the interest in the quality control and stan-
dardization of its preparations. Capillary electrophoresis [14,15],
mass spectrometry, and high-performance liquid chromatography
(HPLC) [16,17] have been used to analyze the polyphenols, but the
analytical procedures were complex, with long analysis times and
dependent on the use of several polyphenols, analytical standards,
and expensive reagents. Some analytical methods have employed
Open access under the Elsevier OA license.HPLC to analyze P. cupana, but most of them describe the separa-
tion of methylxanthines [14,18–20].  Polyphenols, mainly tannins,
have been isolated from other plants, but the method is often time-
consuming (30–36 min  [21]; 50 min  [22]; and 55–106 min  [23]).
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The aim of the present study was to develop and validate
 reversed-phase HPLC-photodiode array (PDA) method for the
eparation and quantiﬁcation of the catechin and epicatechin con-
tituents in semipuriﬁed extract of guaraná. The main validation
arameters of the method were also determined.
. Experimental
.1. Chemicals and reagents
Methanol and acetonitrile (J.T. Baker; HPLC grade), water ﬁl-
ered through a Milli-Q apparatus (Millipore), and triﬂuoroacetic
cid (TFA) (J.T. Baker) were used as the mobile phase. Analytical-
rade standards of catechin, epicatechin, and caffeine (Sigma) were
sed as external standards. Procyanidins B1 and B2 were isolated
nd identiﬁed by Ushirobira et al. [2] and Yamaguti-Sasaki et al. [3].
cetone and ethyl acetate (Merck; analytical grade) were also used.
.2. Apparatus
High performance liquid chromatography analyses were per-
ormed using a Thermo HPLC equipped with pumps and an integral
egasser (Finnigan Surveyor LC Pump Plus), PDA spectrophoto-
etric detector module (Finnigan Surveyor PDA Plus Detector),
ontroller software (Chromquest) and autosampler (Finnigan Sur-
eyor Autosampler Plus) equipped with a 10 L loop and 10 L
njection. Chromatographic separation was accomplished using
 Phenomenex® Synergi POLAR–RP 80A stainless-steel analyti-
al column (250 mm × 4.6 mm,  4 m)  and a Phenomenex® C18
uard cartridge system (4 m,  4.6 mm  × 20 mm).  The mobile phase
sed was a gradient system of 0.05% TFA–water (phase A) and
.05% TFA- acetonitrile:methanol (75:25, v v−1) (phase B), previ-
usly degassed using an ultrasonic bath. The gradient system was
stablished and demonstrated in Section 3. Gradient separation
as performed at a ﬂow rate of 0.5 mL  min−1. Another HPLC anal-
sis was carried out using a different column, a Waters X BridgeTM
18 (100 mm × 4.6 mm,  5 m)  and a Waters X BridgeTM C18 guard
artridge system (5 m,  4.6 mm  × 20 mm).
For the interlaboratory HPLC assay, a different apparatus was
sed, a Gilson HPLC system consisting of a Model 321 pump, a
odel 156 variable-wavelength UV/Vis detector, a Rheodyne man-
al injection valve with a 10 L loop, Model 184 degasser, a Model
31 thermostatted column compartment, and Unipoint LC system
oftware.
.3. Preparation of the EPA extractive solution
Guaraná samples obtained in the municipality of Alta Flo-
esta, state of Mato Grosso, Brazil, were used to prepare the
cetone:water (70:30) extractive solution (ES), by turbo extrac-
ion (Ultra-Turrax UTC115KT, IKA Works, Wilmington, NC, USA).
fter the organic solvent was removed, the remaining solid mate-
ial was lyophilized (EBPC; patent pending PI0006638-9). The EBPC
crude extract) was partitioned with ethyl acetate, resulting in an
thyl-acetate fraction (EPA) [4,13].  The EPA was extracted with
olid-phase extraction (SPE). A 2.00 mg  portion of EPA was diluted
n 1 mL  of 20% methanol and was passed through the SPE cartridge
nd diluted in 25 mL  of 20% methanol. A 10 L aliquot was analyzed
y HPLC.
.4. Method validationFor validation of the analytical method, the guidelines estab-
ished by the ICH (International Conference on the Harmonization
f Technical Requirements for the Registration of Pharmaceuti-
als for Human Use) and by Brazilian regulation RE 899/2003 of8 (2012) 502– 506 503
the National Health Surveillance Agency (ANVISA) were employed
[24,25].
2.4.1. Linearity
Linearity was  determined by the calibration curves obtained
from the HPLC analyses of the standard solutions of catechin and
epicatechin. The range (interval between the upper and lower con-
centrations of analyte in the sample) of the appropriate amount of
samples was  determined. The slope and other statistics of the cali-
bration curves were calculated by linear regression and analysis of
variance (ANOVA).
The catechin and epicatechin standards were dissolved in 20%
methanol to give concentrations of 18.75, 37.5, 75.0, 150, and
300 g mL−1. The solutions were ﬁltered through an FHLP01300
20 m membrane ﬁlter (Millipore). Evaluation of each point was
conducted in ﬁve replicates, and the calibration curve was ﬁtted by
linear regression.
2.4.2. Limit of detection and limit of quantiﬁcation
The limit of detection (LOD) and limit of quantiﬁcation (LOQ)
were calculated based on the standard deviation (SD) and the slope
(S) of the calibration curve based on Eqs. (1) and (2).
LOD = 3.3 × SD
S
(1)
LOQ
10 × SD
S
(2)
2.4.3. Precision
The precision of the method was  determined following ICH
guidelines. Precision was  evaluated at three levels: repeatability,
intermediate precision, and reproducibility. The standard deviation
(SD) and relative standard deviation (RSD) of six injections at 100%
of the test concentration were evaluated and analyzed intra-day
and inter-day, and with different analysts and different apparatus.
2.4.4. Accuracy
The accuracy was  determined by recovery analyses, adding
measured amounts of catechin (100, 50, and 25 g mL−1) and
epicatechin (100, 50, and 25 g mL−1) to EPA extractive solution
samples. The recovery experiments were performed in triplicate.
The recovery data were determined by dividing the value obtained
for the sample prepared with the added standard, by the amount
added, and then multiplying by 100% [24].
2.4.5. Robustness
The robustness was  determined for variations in ﬂow rates,
for 0.495 mL  min−1 and 0.505 mL  min−1. The Tukey test of ANOVA
was  performed to evaluate whether the ﬂow variations altered the
results of the HPLC analysis.
2.4.6. Stability
The stability of the EPA extractive solutions was determined
over a period of four weeks. A 2.00 mg  portion of EPA was diluted
in 1 mL  of 20% methanol. This solution was  passed through the SPE
cartridge and diluted in 25 mL  of 20% methanol. The samples were
stored at room temperature, exposed to light. A 10 L aliquot was
analyzed by HPLC.
2.5. EPA extractive solution quantiﬁcation
The catechin, epicatechin and caffeine calibration curves were
utilized to quantify the EPA extractive solutions. The EPA extractive
solutions were analyzed by HPLC in six replicates. The catechin,
epicatechin, and caffeine peaks were quantiﬁed by linear regression
of the standards.
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Table  1
Mobile phases and ﬂows tested in separation of EPA extractive solutions.
System Phase A Phase B Flow (mL  min−1)
A Water + 5% acetic acid Methanol + 5% acetic acid 0.8
B  Water + 0.5% phosphoric acid Methanol + 0.5% phosphoric acid 0.8
C Water  + 0.05% TFA Acetonitrile + 0.05% TFA 0.5 and 0.8
D  Water + 0.05% TFA Methanol/acetonitrile (50/50) + 0.05% TFA 0.5
E Water  + 0.05% TFA Methanol/acetonitrile (40/60) + 0.05% TFA 0.5
F  Water + 0.05% TFA Methanol/acetonitrile (30/70) + 0.05% TFA 0.5
G  Water + 0.05% TFA Methanol/acetonitrile (25/75) + 0.05% TFA 0.5
H  Water + 0.05% TFA Methanol/acetonitrile (75/25) + 0.05% TFA 0.5
TFA = triﬂuoracetic acid.
Table 2
Curve parameter summary and back-calculation calibration curve concentrations
for catechin, epicatechin, and caffeine.
Catechin Epicatechin Caffeine
Linear range (g mL−1) 300–18.75 300–18.75 50–3.125
Detection limit (g mL−1) 0.70 0.88 0.13
Quantiﬁcation limit (g mL−1) 2.13 2.67 0.39
Regression data*
N 5 5 5
Slope (a) 62438 69637 239600
Standard deviation of slope 1385.35 3152.6 9388.28
Relative standard deviation of slope (%) 2.21 4.53 4.37
Intercept (b) 141240 −153220 165590
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Fig. 1. Chromatogram of EPA extractive solution. Procyanidin B1 (12.24 min), cate-
chin  (15.32 min), procyanidin B2 (17.08 min), epicatechin (17.72 min), and caffeine
T
ACorrelation coefﬁcient (r ) 0.9980 0.9918 0.9930
* y = ax + b, where x is the concentration of the compound and y is the peak area.
. Results and discussion
In this study, the same mobile phase, column, and other
hromatographic conditions were employed throughout. The chro-
atograms were obtained from several different mobile phases and
ows tested (Table 1), in order to establish the ideal conditions for
he analysis of the EPA extractive solution. All analyses were per-
ormed at 210 and 280 nm.  The standard peaks and the EPA multiple
eaks were analyzed in the wavelength range of 200–400 nm.  The
pectra were observed, and the 280 nm wavelength was employed
n all subsequent analyses. Different gradient systems and analysis
imes were tested. System G showed the best performance in the
eparation of EPA multiple peaks, with a possible shorter analysis
ime.
Triﬂuoroacetic acid (TFA) increased the deﬁnition of the peaks,
ompared with acetic and phosphoric acids. System C showed good
eparation and peak deﬁnition. Acetonitrile is an expensive solvent,
nd we tested mixtures with acetonitrile and methanol. System G
ave the best results in the HPLC analysis.
The mobile phases of system G were: Phase A, water plus 0.05%
FA; Phase B, methanol:acetonitrile (25:75) plus 0.05% TFA. The
able 3
NOVA results for linearity of catechin, epicatechin, and caffeine (SS: sums of squares; df
Catechin
SS df 
Model 3.9404 × 1014 1 
Residual 7.8401 × 1011 38 
Lack  of ﬁt 1.1604 × 1011 2 
Pure  error 6.6796 × 1011 36 
Epicatechin
Model 4.2450 × 1014 1 
Residual 3.5278 × 1012 34 
Lack  of ﬁt 1.3037 × 1011 2 
Pure  error 3.3975 × 1012 32 
Caffeine
Model 8.3685 × 1014 1 
Residual 5.8777 × 1012 49 
Lack  of ﬁt 4.1577 × 1011 3 
Pure  error 5.4619 × 1012 46 (19.90 min).
gradient system of the HPLC analysis was  established as: 0 min,
80:20 (A:B); 20 min, 74:26 (A:B); 21 min, 80:20 (A:B); 24 min, 80:20
(A:B). The EPA chromatogram obtained at the 280 nm wavelength
and 0.5 mL  min−1 is shown in Fig. 1.
Evaluation of the EPA by HPLC-PDA was indispensable to deﬁne
certain parameters. By this means, the UV spectra of the catechin
and epicatechin peaks of the EPA fraction were obtained (data not
shown). Comparison of these spectra indicated that these com-
pounds showed two  bands that were very similar to the proﬁle
found for the catechin and epicatechin standards.
The Waters X BridgeTM C18 column (100 mm × 4.6 mm,  5 m)
was  tested in an attempt to decrease the time required and the
volume of solvent used during the analysis. However, under con-
ditions C–H (Table 1) it was not possible to obtain separation of
catechin and epicatechin, and therefore this column was  not used
for the subsequent analyses.
: degrees of freedom; MS:  mean squares; F: F value of the test; Ftab: ﬁxed F value).
MS F Ftab
3.9404 × 1014 19098.60 4.098
2.0631 × 1010 Linear
5.8021 × 1010 3.127043 3.259
1.8554 × 1010 No lack of ﬁt
4.2450 × 1014 4091.133 4.130
1.0376 × 1011 Linear
6.5186 × 1010 0.613969 3.295
1.0617 × 1011 No lack of ﬁt
8.3685 × 1014 6976.483 4.038
1.1995 × 1011 Linear
1.3859 × 1011 1.167205 2.807
1.1873 × 1011 No lack of ﬁt
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Table 4
Repeatability and intermediate precision of EPA extract solution.
RSD%
Intra-day Inter-day Different analyst Different apparatus
Catechin 0.72 0.93 0.19 1.52
Epicatechin 0.66 0.75 0.66 1.95
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with solid-phase extraction was included in the sample preparationSD% = relative standard deviation.
For the validation of an analytical method, the ICH guidelines
ecommend that tests for speciﬁcity, linearity, accuracy, precision,
OD, and LOQ of the method be performed [24].
The linearity of the HPLC method, catechin and epicatechin at
ve concentration levels was investigated. The results are pre-
ented in Table 2.
The calibration curves for catechin and epicatechin were lin-
ar in the range 18.75–300 g mL−1. The representative linear
quations for catechin and epicatechin were y = 141240 + 62438x
n = 5; r2 = 0.9980; RSD = 2.21%) and y = −153220 + 69637x  (n = 5;
2 = 0.9918; RSD = 4.53%), respectively. According to the Analytical
ethods Committee (AMC), a value of regression coefﬁcient close
o unity is not necessarily the outcome of a linear relationship, and
n consequence the test for the lack of ﬁt should be applied. This
est evaluates the variance of the residual values [26]. The ANOVA
or catechin and epicatechin linearity is presented in Table 3. The
 value for lack of ﬁt was smaller than the tabulated F value for
he 95% conﬁdence level (  ˛ = 0.05), and therefore, according to the
NOVA test, the linear regression showed no lack of ﬁt.
The epicatechin RSD% of the slope was 4.53%. This value is within
he limit set by ICH and ANVISA, which is up to 5%. The negative b
alue was in the 95% conﬁdence interval of the calibration curve by
he ANOVA test. These results (RSD% and negative b value) indicate
hat the reproducibility of the method and compound purity are
ithin acceptable limits. The intercept (b value) conﬁdence interval
f the calibration curve of epicatechin was −334848 to 28401.69.
he value obtained in the experiments was within the conﬁdence
nterval (b value was −153220). Similarly to epicatechin, the RSD%
f the slope and the b values of the calibration curves of catechin
nd caffeine were within the limits established by the validation
uidelines.
The values of LOD, taken as the lowest absolute concentration of
nalyte in a sample which can be detected but not necessarily quan-
iﬁed as an exact value under the stated experimental conditions,
ere 0.70 g mL−1 for catechin and 0.88 g mL−1 for epicatechin.
he values of LOQ, taken as the lowest amount of analyte in a
ample which can be quantitatively determined with suitable pre-
ision and accuracy under the stated experimental conditions, were
.13 g mL−1 for catechin and 2.67 g mL−1 for epicatechin.
The repeatability and intermediate precision were determined
y evaluation of the precision and the SD and RSD of six determina-
ions at 100% of the test concentration. Repeatability expresses the
recision under the same operating conditions over a short inter-
al of time. Intermediate precision, expressed as inter-laboratory
ariations with different analysts and different apparatus, was  eval-
ated. The results are shown in Table 4. The data were evaluated
y one-way ANOVA. Statistical comparison of the results was per-
ormed using the P-value of the F-test. Since the P-value of the F-test
as always greater than 0.05, there was no statistically signiﬁcant
ifference between the mean results obtained from one time of
ay to another at the 95% conﬁdence level. This procedure was
erformed to detect any other problems that would be encoun-
ered in a reproducibility study. The variations in ambient factors
hat are expected to occur in practice were simulated, and the
esults conﬁrmed the precision and reproducibility of the method
27].Fig. 2. Four-week evaluation of the stability of the EPA extractive solution.
The accuracy of the HPLC method for the analysis of recovery
assay was  determined by the preparation of a simulated sam-
ple containing a known quantity of catechin and epicatechin. The
recovery of an added standard solution at three levels of concen-
tration (100, 50, and 25 g mL−1) was performed (91.3 ± 3.8%, 2.14
RSD and 93.4 ± 3.1, 2.74 RSD of catechin and epicatechin, respec-
tively). The results refer to the mean of three assays, and they were
in good agreement with the results required for complex matrices
(80–120%) [24].
The robustness should be evaluated during the development
of the HPLC method, and it should demonstrate the reliability of
analysis with respect to deliberate variations in the parameters
of the methods [24]. The Tukey test evaluates whether a differ-
ence exists among the different levels of a factor. At the 5% level,
there were no signiﬁcant differences in the area of the curve and
the retention time of catechin and epicatechin when the ﬂow of
the mobile phase was varied, from 0.500 mL  min−1 to 0.495 and
0.505 mL  min−1. Therefore, the method proved to be robust for the
substances analyzed, under the conditions evaluated.
To demonstrate the stability of the working solutions during the
analysis, the EPA extractive solutions were analyzed over a period of
four weeks while they were stored at room temperature (22 ± 3 ◦C)
with exposure to natural light. The results are shown in Fig. 2.
The retention times and peak areas of the drugs remained almost
unchanged, and no signiﬁcant degradation was observed during
the course of one week, suggesting that these solutions remained
stable for a sufﬁcient time to complete the analytical process.
For quantiﬁcation of the EPA extractive solution, the calibration
curves of catechin, epicatechin, and caffeine were analyzed. The
calibration curves of catechin and epicatechin are shown in Table 2.
The calibration curve of caffeine was  linear in the range
3.125–100 g mL−1. The representative linear equation for caffeine
was  y = 165590 + 239600x (n = 5; r2 = 0.9930; RSD = 4.37%) (Table 2).
The ANOVA for caffeine linearity is given in Table 3. These results
showed that the curve was  linear and there was no lack of ﬁt in the
linear regression (Table 3).
The quantiﬁcation of the EPA extractive solution demon-
strated that it contained 14.46 g mL−1 of catechin (180.75 g
catechin mg−1 of EPA), 22.31 g mL−1 of epicatechin (278.87 g
epicatechin mg−1 of EPA), and 24.07 g mL−1 of caffeine (300.87 g
caffeine mg−1 of EPA).
4. Conclusion
A reversed-phase HPLC-PDA method was developed to deter-
mine the amount of catechin and epicatechin in the P. cupana EPA
semipuriﬁed extract. Because of the complexity of the extract and
in order to eliminate column-blocking compounds, a cleaning stepprotocol.
The method was validated according to the ICH guidelines and
Brazilian regulations. In this study, the HPLC-PDA method proved to
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